AP NEWS

Global Sterile Injectable Drugs Market to 2023 by Molecule Type, Drug Class, Application and Geography - ResearchAndMarkets.com

October 1, 2018

DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Global Sterile Injectable Drugs Market - Segmented by Molecule Type, Drug Class, Application and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The sterile injectable drugs market is expected to register a growth rate of about 10.5% over the forecast period, 2018 to 2023.

The increasing number of biologics, antibody-drug conjugates, and monoclonal antibodies in development, as well as clinical trials, has led primarily led to the growth of the sterile injectable drugs. The development and manufacture of the sterile injectable are slow and often the industry deals with the shortage of these products primarily due to the complexity and capital-intensive nature of these products.

As per the regional analysis, the recent changes in the US Food and Drug Administration (FDA) regulations on manufacturing sites, along with large presence of multinational medical devices companies, diseases management and awareness in the society are expected to have positive effects over the forecast period, which helps North America to retain its dominance in this market.

In the past one era of healthcare, biologics are increasingly becoming the driving forces of the pharmaceutical industry and prefilled syringes have gained increased acceptance as delivery systems for injectable drugs for the treatment of chronic diseases. Prefilled syringes are mainly sterilized via autoclaving or by ionizing radiation.

Market Dynamics

Market Drivers

Rising R&D Focus on Development of Biotechnology-Engineered Anti-Cancer Drugs Rapid Growth in the Usage of in Pre-filled Syringes for Biologic Products Increased out-sourcing Activities across Value Chain Expected to Boost Supply of Injectable Products

Market Restraints

High Expenses Associated with Inventory Management Stringent Regulatory Requirement for High-End Machinery

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Competitive Landscape

9. Key Players

Amgen Baxter Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Merck & Co. Inc Novartis AG Novo Nordisk A/S Pfizer Inc Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/r7b55w/global_sterile?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005646/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infusions and Injectables

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/01/2018 10:35 AM/DISC: 10/01/2018 10:35 AM

http://www.businesswire.com/news/home/20181001005646/en

AP RADIO
Update hourly